bioRxiv preprint doi: https://doi.org/10.1101/2021.01.29.428852; this version posted January 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Single-cell sequencing reveals clonally expanded plasma cells during chronic viral infection produce virus-specific and cross-reactive antibodies Daniel Neumeier1, Alessandro Pedrioli2 , Alessandro Genovese2, Ioana Sandu2, Roy Ehling1, Kai-Lin Hong1, Chrysa Papadopoulou1, Andreas Agrafiotis1, Raphael Kuhn1, Damiano Robbiani1, Jiami Han1, Laura Hauri1, Lucia Csepregi1, Victor Greiff3, Doron Merkler4,5, Sai T. Reddy1,*, Annette Oxenius2,*, Alexander Yermanos1,2,4,* 1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland 2Institute of Microbiology, ETH Zurich, Zurich, Switzerland 3Department of Immunology, University of Oslo, Oslo, Norway 4Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland 5Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland *Correspondence:
[email protected] ;
[email protected] ;
[email protected] Graphical abstract. Single-cell sequencing reveals clonally expanded plasma cells during chronic viral infection produce virus-specific and cross-reactive antibodies. bioRxiv preprint doi: https://doi.org/10.1101/2021.01.29.428852; this version posted January 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Neumeier et al., Abstract Plasma cells and their secreted antibodies play a central role in the long-term protection against chronic viral infection.